#MSCOVID19 – AstraZenca Vaccine Update

Barts-MS rose-tinted-odometer: ★★ In response to a comment from one of our readers. We have not directly addressed the thrombosis AstraZeneca vaccine issue as we are not vaccinologists or haematologists. But as there seems to a lot of anxiety around this issue a short blog post about the potential risks may allay your fears. I received the following email, from Professor Marcel Levy (Consultant...

#MSCOVID19: transverse myelitis

Barts-MS rose-tinted-odometer: ★★ How do you distinguish transverse myelitis that is not MS-related from spinal cord involvement in MS?  Yesterday after reporting the possible and likely link between the Oxford-AstraZenca vaccine and transverse myelitis (TM) and possibly MS you asked how do neurologists differentiate TM from CIS or MS.  Idiopathic or post-infectious/vaccine-related TM...

#MSCOVID19: vaccine readiness

Will Prof G have to eat his proverbial hat? I have been telling people that an effective SARS-CoV-2 vaccine is a long way away and that we shouldn’t expect a commercially available vaccine for another 12-18 months. Maybe I am wrong. The Moderna phase 1 results were published by the NEJM yesterday and are more impressive than I expected. These results are so important because the vaccine is...

EBV and MS

This is not about coronavirus. Epstein-Barr Virus is an(other) extremely common virus which has infected the vast majority of people (~95%) by their late 20s. Unlike coronavirus, EBV has co-evolved with humans and the observation that it is so ubiquitous suggests that it actually may confer some kind of evolutionary benefit, e.g. by enhancing the host’s ability to respond to novel...



Recent Posts

Recent Comments